1. Nanoliposomal Irinotecan and Metronomic Temozolomide for Patients With Recurrent Glioblastoma: BrUOG329, A Phase I Brown University Oncology Research Group Trial. (February 2021) Authors: Elinzano, Heinrich; Toms, Steven; Robison, Jordan; Mohler, Alex; Carcieri, Arieana; Cielo, Deus; Donnelly, Jennifer; Disano, Dylan; Vatketich, John; Baekey, John; Sturtevant, Ashlee; MacKinnon, Kelsey; Wood, Roxanne; Safran, Howard Journal: American journal of clinical oncology Issue: Volume 44:Number 2(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗